First Time Loading...

Zepp Health Corp
NYSE:ZEPP

Watchlist Manager
Zepp Health Corp Logo
Zepp Health Corp
NYSE:ZEPP
Watchlist
Price: 0.853 USD 1.55% Market Closed
Updated: Apr 29, 2024

Gross Margin
Zepp Health Corp

22.6%
Current
20%
Average
24.4%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
22.6%
=
Gross Profit
671.2m
/
Revenue
3B

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
CN
Zepp Health Corp
NYSE:ZEPP
52.1m USD
23%
JP
Keyence Corp
TSE:6861
16.9T JPY
82%
CN
Hangzhou Hikvision Digital Technology Co Ltd
SZSE:002415
310.1B CNY
43%
SE
Hexagon AB
STO:HEXA B
322.7B SEK
66%
US
Keysight Technologies Inc
NYSE:KEYS
26B USD
65%
IL
Mobileye Global Inc
NASDAQ:MBLY
23.5B USD
48%
US
Teledyne Technologies Inc
NYSE:TDY
17.7B USD
43%
US
Zebra Technologies Corp
NASDAQ:ZBRA
15.3B USD
46%
US
Trimble Inc
NASDAQ:TRMB
14.8B USD
61%
UK
Halma PLC
LSE:HLMA
8.4B GBP
0%
US
Coherent Inc
NASDAQ:COHR
8.4B USD
31%
Zepp Health Corp
NYSE:ZEPP
Country CN
Market Cap 52.1m USD
Gross Margin
23%
Keyence Corp
TSE:6861
Country JP
Market Cap 16.9T JPY
Gross Margin
82%
Hangzhou Hikvision Digital Technology Co Ltd
SZSE:002415
Country CN
Market Cap 310.1B CNY
Gross Margin
43%
Hexagon AB
STO:HEXA B
Country SE
Market Cap 322.7B SEK
Gross Margin
66%
Keysight Technologies Inc
NYSE:KEYS
Country US
Market Cap 26B USD
Gross Margin
65%
M
Mobileye Global Inc
NASDAQ:MBLY
Country IL
Market Cap 23.5B USD
Gross Margin
48%
Teledyne Technologies Inc
NYSE:TDY
Country US
Market Cap 17.7B USD
Gross Margin
43%
Zebra Technologies Corp
NASDAQ:ZBRA
Country US
Market Cap 15.3B USD
Gross Margin
46%
Trimble Inc
NASDAQ:TRMB
Country US
Market Cap 14.8B USD
Gross Margin
61%
Halma PLC
LSE:HLMA
Country UK
Market Cap 8.4B GBP
Gross Margin
0%
Coherent Inc
NASDAQ:COHR
Country US
Market Cap 8.4B USD
Gross Margin
31%

Profitability Report

View the profitability report to see the full profitability analysis for Zepp Health Corp.

Full Profitability Report

See Also

Summary
ZEPP intrinsic value, competitors valuation, and company profile.
DCF Valuation
ZEPP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ZEPP stock valuation using valuation multiples.
Wall Street Estimates
ZEPP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ZEPP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
22.6%
=
Gross Profit
671.2m
/
Revenue
3B
What is the Gross Margin of Zepp Health Corp?

Based on Zepp Health Corp's most recent financial statements, the company has Gross Margin of 22.6%.

ALPHA SPREAD
Join more than 132,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.